Eliem Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELYM and other ETFs, options, and stocks.About ELYM
Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems.
CEOAndrew D. Levin
CEOAndrew D. Levin
Employees9
Employees9
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2018
Founded2018
Employees9
Employees9
ELYM Key Statistics
Market cap280.29M
Market cap280.29M
Price-Earnings ratio-7.73
Price-Earnings ratio-7.73
Dividend yield—
Dividend yield—
Average volume965.88K
Average volume965.88K
High today$11.53
High today$11.53
Low today$8.02
Low today$8.02
Open price$8.40
Open price$8.40
Volume1.48M
Volume1.48M
52 Week high$11.55
52 Week high$11.55
52 Week low$2.34
52 Week low$2.34